Novel collaborative practice model for treatment of mental illness in indigent and uninsured patients

American Journal of Health-System Pharmacy

Volumn 69, Issue 12, 2012, Pages 1054-1062

  Buxton, Jennifer Askew ^a   Chandler Altendorf, Alison ^a   Puente, Antonio E ^a  

^a Cape Fear Clinic   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; HEALTH INSURANCE; HUMAN; INDIGENT; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; MENTAL HEALTH SERVICE; PATIENT COUNSELING; PHARMACIST; PRESCRIPTION; PRIORITY JOURNAL; PROFESSIONAL PRACTICE; PSYCHOLOGIST; PSYCHOTHERAPY; QUESTIONNAIRE; SCORING SYSTEM; SHORT FORM 12;

EID: 84862902789     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110421     Document Type: Article

References (29)

1. Centers for Medicare and Medicaid Services, Department of Health and Human Services. NHE Fact Sheet 2009. www.cms.gov/National HealthExpendData/25- NHE-Fact-Sheet.asp (accessed 2010 Oct 31).
2. Centers for Disease Control and Prevention. Health Data Interactive. http://205.207.175.93/hdi/Repor t Folders/ReportFolders.aspx?IF-Active Path=P,20 (accessed 2010 Oct 20).
3. Herbert C. Changing the culture: interprofessional education for collaborative patient-centred practice in Canada. J Interprof Care. 2005; 19(suppl 1):1-4. (Pubitemid 40960280)
4. Snyder ME, Zillich AJ, Primack BA et al. Exploring successful community pharmacist-physician collaborative working relationships using mixed methods. Res Social Adm Pharm. 2010; 6:307-23.
5. Miller SW, Darsey E, Heard TJ et al. Outcomes of a multidisciplinary partnership to improve cardiac wellness: an opportunity for pharmacists. Consult Pharm. 2010; 25:105-16.
6. Weber CA, Ernst ME, Sezate GS et al. Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures. Arch Intern Med. 2010; 170:1634-9.
7. Rochester CD, Leon N, Dombrowski R et al. Collaborative drug therapy management for initiating and adjusting insulin therapy in patients with type 2 diabetes mellitus. Am J Health-Syst Pharm. 2010; 67:42-8.
8. Wilson S, Wahler R, Brown J et al. Impact of pharmacist intervention on clinical outcomes in the palliative care setting. Am J Hosp Palliat Care. 2011; 28:316-20.
9. Jennings HR, Miller EC, Williams TS et al. Reducing anticoagulant medication adverse events and avoidable patient harm. Jt Comm J Qual Patient Saf. 2008; 34:196-200.
10. Pyne JM, Fortney JC, Tripathi SP et al. Cost-effectiveness analysis of a rural telemedicine collaborative care intervention for depression. Arch Gen Psychiatry. 2010; 67:812-21.
11. U.S. Census Bureau. Poverty thresholds 2009. www.census.gov/hhes/www/ poverty/data/threshld/thresh09.html (accessed 2010 Oct 31).
12. North Carolina Board of Pharmacy. Clinical Pharmacist Practitioners. www.ncbop.org/pharmacists-cpp.htm (accessed 2011 Sep 20).
13. North Carolina Medical Board. NCMB licensee search. wwwapps.ncmed board.org/Clients/NCBOM/Public/ LicenseeInformationResults.aspx (accessed 2011 Sep 20).
14. Cujipers P, van Straten A, Warmerdam L et al. Psychotherapy versus the combination of psychotherapy and pharmacotherapy in the treatment of depression: a meta-analysis. Depress Anxiety. 2009; 26:279-88.
15. Gorman JM, ed. A complimentary relationship: psychotherapy and medication for anxiety and depressive disorders. CNS Spectr. 2003; 8:326. Editorial.
16. Solomon DA, Keitner GI, Rayn CE et al. Preventing recurrence of bipolar I mood episodes and hospitalizations: family psychotherapy plus pharmacotherapy versus pharmacotherapy alone. Bipolar Disord. 2008; 10:798-805.
17. American Psychiatric Association. Clinical practice guidelines. www.psychiatry.org/ practice/clinical-practice-guidelines (accessed 2012 Apr 17).
18. Wechsler D. Wechsler Adult Intelligence Scale - 3rd edition (WAIS-3). San Antonio, TX: Harcourt Assessment; 1997.
19. Reitan RM, Wolfson D. The Halstead- Reitan Neuropsychological Test Battery: theory and clinical interpretation (2nd edition). Tucson, AZ: Neuropsychology Press; 1993.
20. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12:189-98.
21. Butcher JN, Dahlstrom WG, Graham JR et al. Minnesota Multiphasic Personality Inventory - 2 (MMPI - 2): manual for administration and scoring. Minneapolis: University of Minnesota Press; 1989.
22. Ware J Jr, Kosinski M, Keller SD. A 12-item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996; 34:220-33. (Pubitemid 126433231)
23. Babor TF, Higgins-Biddle JC, Saunders JB et al. AUDIT: the Alcohol Use Disorders Identification Test - guidelines for use in primary care. 2nd ed. Geneva: World Health Organization; 2001.
24. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic and severity measure. Psychiatr Ann. 2002; 32:509-15. (Pubitemid 37346793)
25. Finley PR, Bluml JM, Bunting BA et al. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression. J Am Pharm Assoc. 2011; 51:40-9.
26. Petersen TJ. Enhancing the efficacy of antidepressants with psychotherapy. J Psychopharmacol. 2006; 20:19-28. (Pubitemid 44605929)
27. Friedman MA, Detweiler-Bedell JB, Leventhal HE et al. Combined psychotherapy and pharmacotherapy for the treatment of major depressive disorder. Clin Psychol Sci Pract. 2004; 11:47-68. (Pubitemid 38735568)
28. Areán PA, Cook BL. Psychotherapy and combined psychotherapy/ pharmacotherapy for late life depression. Biol Psychiatry. 2002; 52:293-303. (Pubitemid 35232095)
29. U.S. Census Bureau. Hispanics in the United States. www.census.gov/ population/www/socdemo/hispanic/hispanic-pop-presentation.html (accessed 2012 Apr 18).